tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RNAZ Stock Latest News

TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138
Company AnnouncementsTransCode Therapeutics Completes Phase 1a Trial for TTX-MC138
5d ago
8K
RNAZ
Transcode Therapeutics’ TTX-MC138 achieves safety endpoint in Phase 1a study
PremiumThe Fly
Transcode Therapeutics’ TTX-MC138 achieves safety endpoint in Phase 1a study
5d ago
RNAZ
TransCode Therapeutics Acquires Polynoma and Secures Investment
PremiumCompany Announcements
TransCode Therapeutics Acquires Polynoma and Secures Investment
11d ago
8K
RNAZ
Transcode Therapeutics Inc trading resumes
PremiumThe Fly
Transcode Therapeutics Inc trading resumes
11d ago
RNAZ
Transcode Therapeutics Inc trading halted, volatility trading pause
PremiumThe Fly
Transcode Therapeutics Inc trading halted, volatility trading pause
11d ago
RNAZ
Transcode Therapeutics to acquire Polynoma
PremiumThe FlyTranscode Therapeutics to acquire Polynoma
11d ago
RNAZ
TransCode Therapeutics Amends Patent License Agreement
Premium
Company Announcements
TransCode Therapeutics Amends Patent License Agreement
16d ago
8K
RNAZ
TransCode Therapeutics Passes Key Proposals at Annual Meeting
Premium
Company Announcements
TransCode Therapeutics Passes Key Proposals at Annual Meeting
2M ago
8K
RNAZ
Transcode Therapeutics Inc trading resumes
PremiumThe Fly
Transcode Therapeutics Inc trading resumes
3M ago
RNAZ
Transcode Therapeutics Inc trading halted, volatility trading pause
PremiumThe Fly
Transcode Therapeutics Inc trading halted, volatility trading pause
3M ago
RNAZ
TransCode Therapeutics Announces 2025 Annual Meeting Date
PremiumCompany Announcements
TransCode Therapeutics Announces 2025 Annual Meeting Date
4M ago
8K
RNAZ
Transcode Therapeutics Inc trading halted, news pending
PremiumThe Fly
Transcode Therapeutics Inc trading halted, news pending
5M ago
RNAZ
Upcoming Stock Splits This Week (May 12 to May 16) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (May 12 to May 16) – Stay Invested
5M ago
STI
ALZN
Transcode Therapeutics completes dosing of patients in Phase 1a cancer trial
Premium
The Fly
Transcode Therapeutics completes dosing of patients in Phase 1a cancer trial
5M ago
RNAZ
TransCode Therapeutics Faces Nasdaq Delisting Risk
Premium
Company Announcements
TransCode Therapeutics Faces Nasdaq Delisting Risk
5M ago
8K
RNAZ
TransCode Therapeutics Announces Reverse Stock Split
PremiumCompany Announcements
TransCode Therapeutics Announces Reverse Stock Split
6M ago
8K
RNAZ
TransCode Therapeutics Announces Reverse Stock Split Approval
PremiumCompany Announcements
TransCode Therapeutics Announces Reverse Stock Split Approval
6M ago
8K
RNAZ
Transcode Therapeutics announces 1-for-28 reverse stock split
PremiumThe Fly
Transcode Therapeutics announces 1-for-28 reverse stock split
6M ago
RNAZ
TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138
PremiumTipRanks Newswire
TransCode Therapeutics (NASDAQ: RNAZ) Advances Phase 1a Trial of RNA Cancer Therapy TTX-MC138
6M ago
RNAZ
Transcode Therapeutics’ TTX-MC138 shows no toxicities in Phase 1a cancer trial
PremiumThe FlyTranscode Therapeutics’ TTX-MC138 shows no toxicities in Phase 1a cancer trial
6M ago
RNAZ
Transcode Therapeutics price target lowered to $10 from $20 at H.C. Wainwright
Premium
The Fly
Transcode Therapeutics price target lowered to $10 from $20 at H.C. Wainwright
6M ago
RNAZ
TransCode Therapeutics Delays Annual Report Filing
Premium
Company Announcements
TransCode Therapeutics Delays Annual Report Filing
7M ago
RNAZ

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >